In eyes with retinal vein occlusion (RVO) with macular edema treated with anti-vascular endothelial growth factor (anti-VEGF) agents, there have been conflicting conclusions regarding whether CST correlates with visual acuity (VA), potentially related to limitations or interpretations of methods used. The gene discussed is VEGFA; the disease is retinal vein occlusion.